Archive for January, 2009

Oakland Tribune - FDA investigating link between allergy drug, suicide

Friday, January 9th, 2009

WASHINGTON — The Food and Drug Administration said Thursday it is investigating a possible link between Merck’s best-selling Singulair and suicide.
The FDA said it is reviewing a handful of reports involving m…

Chain Drug Review - Risk dismissed

Tuesday, January 6th, 2009

No evidence exists that use of Singulair, an asthma/allergy drag, increases the risk of depression or suicide, according to data from three clinical trials. The trials, conducted by the American Lung Association, are highlighted in the Journal of Allergy and Clinical Immunology. The drug is also known by the genetic name of montelukast.

Related Results

SingulairSingulair labelSingulair Sales.Singulair, vera…

Adverse Event Reporting News - FDA reviewing safety of Merck, Mylan drugs

Sunday, January 4th, 2009

FDA March 27 announced it is investigating a possible link between suicidal behavior and the use of several popular asthma drugs, including Merck’s Singulair and Mylan Laboratories’ Zyflo.
Singulair is a medicine in the drug class known as leukotriene receptor antagonists, used to treat asthma and the symptoms of allergic rhinitis (sneezing, stuffy nose, runny nose, itching of the nose) and to prevent exercise-induced asthma.
Ov…

Asthma Treatment Using Singulair During Pregnancy

Thursday, January 1st, 2009

If you are an asthma sufferer, then Singulair might be familiar to you. Singulair has been known as a safe medication for treating asthma. But a problem will occur when a woman who suffer from asthma gets pregnant. “What if I had asthma symptoms during my pregnancy? Is it safe to take Singulair during pregnancy?”
Singulair is a leucotriene (a chemical that cause inflam…